Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-07-025510
Filing Date
2007-04-25
Accepted
2007-04-25 19:38:06
Documents
2
Period of Report
2007-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2149
2 POA DOCUMENT poa.txt EX-24.3_183900 2970
  Complete submission text file 0001209191-07-025510.txt   6892
Mailing Address C/O DOMAIN ASSOCIATES ONE PALO SQ PRINCETON NJ 08542
Business Address
WEBER ECKARD (Reporting) CIK: 0001279800 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 07788888

Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130 (858) 436-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations